Back to companies

Takeda Pharmaceutical Co Ltd: Overview

Takeda Pharmaceutical Co Ltd (Takeda) is a research-based pharmaceutical company which focuses on the discovery, development, manufacturing, marketing, commercialization, import and export of pharmaceutical drugs. The company offers products in the areas of rare diseases, gastrointestinal, oncology, neuroscience, vaccines, and plasma-derived therapies. Takeda has facilities in Japan, Argentina, Brazil, Mexico, the US, Denmark, Norway, Europe, Poland, Russia, Spain, Switzerland, China and India, Canada among others. It markets products directly and through a network of wholesale distributors, retail chains and other purchasing groups worldwide. Takeda has partnership with academic institutions, small biotech, and large pharmaceutical companies. It has presence in the Americas, Europe, and Asia, among others. Takeda is headquartered in Tokyo, Japan.

Headquarters Japan

Address 4f, 2-1-1, Nihombashihon-Cho, Chuo-Ku, Tokyo, 103-8668


Telephone 81 3 32782111

No of Employees 47,347

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange 4502 (TYO)

Revenue (2022) $31.8B 11.6% (2022 vs 2021)

EPS XXX

Net Income (2022) XXX -38.8% (2022 vs 2021)

Market Cap* $46.2B

Net Profit Margin (2022) XXX -45.2% (2022 vs 2021)

* As of and is in US$

Access premium data and analytics for Takeda Pharmaceutical Co Ltd

3,200+

Clinical Trials

Determine Takeda Pharmaceutical Co Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

1,100+

Catalyst Calendar

Proactively evaluate Takeda Pharmaceutical Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

790+

Pipeline Drugs

Identify which of Takeda Pharmaceutical Co Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

790+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Takeda Pharmaceutical Co Ltd’s relevant decision makers and contact details.

430+

Marketed Drugs

Understand Takeda Pharmaceutical Co Ltd’s commercialized product portfolio to stay one step ahead of the market.

420+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

110+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Takeda Pharmaceutical Co Ltd and assess market opportunity for new entrants with patient population 8-year forecasts.

100+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

7

Investigators

Review investigator profiles and find information on trial contacts across Takeda Pharmaceutical Co Ltd, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

470+

Install Base

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

190+

Consumer Market Data Insights

Gain insights from product sales across markets, product categories and channels. Get intelligence on market shares, retail sales footprint, market position and strength for consumer segments and geographies.

30+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

20+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

12+

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

3

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Takeda Pharmaceutical Co Ltd (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Takeda Pharmaceutical Co Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Therapy Areas: Actos
Oncology Blopress
Gastroenterology Takepron
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Regulatory Approval In November, the company announced that the U.S. Food and Drug Administration (FDA) granted the Biologics License Application (BLA) for TAK-003.
2022 Contracts/Agreements In October, the company, Zedira and Dr. Falk Pharma GmbH announced a partnership to develop ZED1227/TAK-227, a Phase 2b investigational therapy for the treatment of celiac disease.
2022 Contracts/Agreements In September, the company entered into a partnership with the United Nations Institute for Training and Research for a new joint initiative focused on strengthening countries’ healthcare systems to meet patients’ need for plasma and plasma-derived therapies.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Takeda Pharmaceutical Co Ltd Pfizer Inc F. Hoffmann-La Roche Ltd AbbVie Inc Novartis AG
Headquarters Japan United States of America Switzerland United States of America Switzerland
City Chuo-Ku New York Basel North Chicago Basel
State/Province Tokyo New York - Illinois -
No. of Employees 47,347 79,000 100,920 50,000 108,000
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Christophe Weber Chief Executive Officer; Director; President Executive Board 2015 56
Costa Saroukos Chief Financial Officer; Director Executive Board 2018 51
Lauren Duprey Chief Human Resources Officer Senior Management 2019 38
Mwana Lugogo Chief Ethics & Compliance Officer Senior Management 2015 52
Takako Ohyabu Chief Global Corporate Affairs Officer Senior Management - 43
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company Analytics

Contact the team or request a demo to find out how our data can drive your business forward

Why are you leaving?